Primatene Mist First-Quarter Sales Grow 43% As Amphastar Expands Distribution
Executive Summary
Sales of Primatene Mist and other higher-margin products drive Amphastar's ifrst-quarter r5esults. The company continues to target a combined market worth around $10.5bn with seven generics in development.